Table of Contents

Global Hemato Oncology Testing Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Hemato Oncology Testing Market Size 2014-2024
  • 2.1.2 Hemato Oncology Testing Market Size CAGR by Region
• 2.2 Hemato Oncology Testing Segment by Type
  • 2.2.1 Leukemia Testing
  • 2.2.2 Leukemia Testing
  • 2.2.3 Multiple Myeloma Testing
  • 2.2.4 Other
• 2.3 Hemato Oncology Testing Market Size by Type
  • 2.3.1 Global Hemato Oncology Testing Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Hemato Oncology Testing Market Size Growth Rate by Type (2014-2019)
• 2.4 Hemato Oncology Testing Segment by Application
  • 2.4.1 Clinical Laboratories
  • 2.4.2 Hospitals
• 2.5 Hemato Oncology Testing Market Size by Application
  • 2.5.1 Global Hemato Oncology Testing Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Hemato Oncology Testing Market Size Growth Rate by Application (2014-2019)

3 Global Hemato Oncology Testing by Players

• 3.1 Global Hemato Oncology Testing Market Size Market Share by Players
  • 3.1.1 Global Hemato Oncology Testing Market Size by Players (2017-2019)
  • 3.1.2 Global Hemato Oncology Testing Market Size Market Share by Players (2017-2019)
• 3.2 Global Hemato Oncology Testing Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Hemato Oncology Testing by Regions

• 4.1 Hemato Oncology Testing Market Size by Regions
• 4.2 Americas Hemato Oncology Testing Market Size Growth
• 4.3 APAC Hemato Oncology Testing Market Size Growth
• 4.4 Europe Hemato Oncology Testing Market Size Growth
• 4.5 Middle East & Africa Hemato Oncology Testing Market Size Growth

5 Americas

• 5.1 Americas Hemato Oncology Testing Market Size by Countries
• 5.2 Americas Hemato Oncology Testing Market Size by Type
• 5.3 Americas Hemato Oncology Testing Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Hemato Oncology Testing Market Size by Countries
• 6.2 APAC Hemato Oncology Testing Market Size by Type
• 6.3 APAC Hemato Oncology Testing Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Hemato Oncology Testing by Countries
• 7.2 Europe Hemato Oncology Testing Market Size by Type
• 7.3 Europe Hemato Oncology Testing Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Hemato Oncology Testing by Countries
• 8.2 Middle East & Africa Hemato Oncology Testing Market Size by Type
• 8.3 Middle East & Africa Hemato Oncology Testing Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Hemato Oncology Testing Market Forecast

• 10.1 Global Hemato Oncology Testing Market Size Forecast (2019-2024)
• 10.2 Global Hemato Oncology Testing Forecast by Regions
  • 10.2.1 Global Hemato Oncology Testing Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Hemato Oncology Testing Forecast by Type
• 10.8 Global Hemato Oncology Testing Forecast by Application

11 Key Players Analysis

• 11.1 QIAGEN N.V.
  • 11.1.1 Company Details
  • 11.1.2 Hemato Oncology Testing Product Offered
  • 11.1.3 QIAGEN N.V. Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 QIAGEN N.V. News
• 11.2 Adaptive Biotechnologies
  • 11.2.1 Company Details
  • 11.2.2 Hemato Oncology Testing Product Offered
  • 11.2.3 Adaptive Biotechnologies Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Adaptive Biotechnologies News
• 11.3 Abbott Laboratories
  • 11.3.1 Company Details
  • 11.3.2 Hemato Oncology Testing Product Offered
  • 11.3.3 Abbott Laboratories Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Abbott Laboratories News
• 11.4 F. Hoffmann-La Roche
  • 11.4.1 Company Details
  • 11.4.2 Hemato Oncology Testing Product Offered
  • 11.4.3 F. Hoffmann-La Roche Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 F. Hoffmann-La Roche News
• 11.5 Bio-Rad Laboratories
  • 11.5.1 Company Details
  • 11.5.2 Hemato Oncology Testing Product Offered
  • 11.5.3 Bio-Rad Laboratories Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Bio-Rad Laboratories News
• 11.6 Thermo Fisher Scientific
  • 11.6.1 Company Details
  • 11.6.2 Hemato Oncology Testing Product Offered
  • 11.6.3 Thermo Fisher Scientific Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Thermo Fisher Scientific News
• 11.7 Invivoscribe
  • 11.7.1 Company Details
  • 11.7.2 Hemato Oncology Testing Product Offered
  • 11.7.3 Invivoscribe Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Invivoscribe News
• 11.8 Illumina
  • 11.8.1 Company Details
  • 11.8.2 Hemato Oncology Testing Product Offered
  • 11.8.3 Illumina Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.8.4 Main Business Overview
  • 11.8.5 Illumina News
• 11.9 Asuragen
  • 11.9.1 Company Details
  • 11.9.2 Hemato Oncology Testing Product Offered
  • 11.9.3 Asuragen Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.9.4 Main Business Overview
  • 11.9.5 Asuragen News
• 11.10 MolecularMD
  • 11.10.1 Company Details
  • 11.10.2 Hemato Oncology Testing Product Offered
  • 11.10.3 MolecularMD Hemato Oncology Testing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.10.4 Main Business Overview
  • 11.10.5 MolecularMD News
• 11.11 ArcherDx
• 11.12 ARUP Laboratories

12 Research Findings and Conclusion

According to this study, over the next five years the Hemato Oncology Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Hemato Oncology Testing business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Hemato Oncology Testing market by product type, application, key companies and key regions.

This study considers the Hemato Oncology Testing value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Leukemia Testing
Acute Myeloid Testing
Multiple Myeloma Testing
Other

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Clinical Laboratories
Hospitals

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
QIAGEN N.V.
Adaptive Biotechnologies
Abbott Laboratories
F. Hoffmann-La Roche
Bio-Rad Laboratories
Thermo Fisher Scientific
Invivoscribe
Illumina
Asuragen
MolecularMD
ArcherDx
ARUP Laboratories

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Hemato Oncology Testing market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hemato Oncology Testing market by identifying its various subsegments.
Focuses on the key global Hemato Oncology Testing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hemato Oncology Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Hemato Oncology Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.